ITeos Therapeutics Inc is a biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ITOS is expected to report earnings to -104 cents per share on March 19
Q4'24
Est.
$-1.05
Q3'24
Beat
by $0.12
Q2'24
Beat
by $0.86
Q1'24
Missed
by $0.09
Q4'23
Missed
by $0.02
The last earnings report on November 12 showed earnings per share of -104 cents, beating the estimate of -116 cents. With 644.75K shares outstanding, the current market capitalization sits at 265.24M.